Alpha 2.0
Login Register
» Authors » Josef Herzog

Josef Herzog

Explore the profile of Josef Herzog including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 832
Followers 0
Related Specialties
Oncology
Science
General Medicine
Top 10 Co-Authors
Jeffrey N Weitzel
Danielle Castillo
Susan L Neuhausen
Banu K Arun
Yael Laitman
Lesley McGuffog
Fergus J Couch
Alfons Meindl
Jenny Lester
Marco Montagna
Published In
PLoS One
Cancer Genet
Cancer Epidemiol Biomarkers Prev
Nat Commun
PLoS Genet
Affiliations
Soon will be listed here.
Recent Articles
1.
Lynch syndrome in Mexican-Mestizo families: Genotype, phenotypes, and challenges in cascade testing among relatives at risk
Rivero-Garcia P, Chavarri-Guerra Y, Rodriguez Olivares J, Weitzel J, Herzog J, Candanedo-Gonzalez F, et al.
Heliyon . 2024 Jul; 10(11):e31855. PMID: 38947473
Lynch syndrome (LS) is the most frequent cancer predisposition syndrome affecting the colon and rectum. A pathogenic variant (PV) disrupting one of the mismatch repair (MMR) genes is responsible for...
2.
Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer
Chavarri-Guerra Y, Bourlon M, Rodriguez-Olivares J, Orozco L, Bazua D, Rodriguez-Faure A, et al.
Clin Genitourin Cancer . 2023 Jun; 21(5):569-573. PMID: 37380563
Background: Early identification of germline mutation carriers may be relevant for the optimal management of prostate cancer and to inform cancer risk in relatives. However, population minorities have limited access...
3.
Influence of germline genotype on the survival of patients with triple-negative breast cancer
Villarreal-Garza C, Ferrigno A, Aranda-Gutierrez A, Frankel P, Ruel N, Fonseca A, et al.
Cancer Res Commun . 2022 Jul; 1(3):140-147. PMID: 35875314
The presence of pathogenic variants (PVs) in triple-negative breast cancer (TNBC) is associated with a distinctive genomic profile that makes the tumor particularly susceptible to DNA-damaging treatments. However, patients with...
4.
Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status
Castillo D, Yuan T, Nehoray B, Cervantes A, Tsang K, Yang K, et al.
Cancer Epidemiol Biomarkers Prev . 2022 Jun; 31(8):1621-1629. PMID: 35654360
Background: Though germline TP53 pathogenic/likely pathogenic variants (PV) are associated with Li-Fraumeni syndrome, many detected by multigene panels represent aberrant clonal expansion (ACE), most due to clonal hematopoiesis (CH). Discerning...
5.
Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancer
Chavarri-Guerra Y, Villarreal-Garza C, Ferrigno A, Mohar A, Aguilar D, Alvarez-Gomez R, et al.
Salud Publica Mex . 2022 Apr; 64(1):41-48. PMID: 35438911
Objective: Describe the prevalence of breast cancer (BC)- associated germline pathogenic variants (PVs) among Mexican patients with triple-negative BC (TNBC). Materials And Methods: The spectrum of PVs identified among patients...
6.
Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in Mexico
Blazer K, Chavarri-Guerra Y, Garza C, Nehoray B, Mohar A, Daneri-Navarro A, et al.
JCO Glob Oncol . 2021 Jun; 7:992-1002. PMID: 34181458
Purpose: Genomic cancer risk assessment (GCRA) is standard-of-care practice that uses genomic tools to identify individuals with increased cancer risk, enabling screening for early detection and cancer prevention interventions. GCRA...
7.
Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis
Slavin T, Sun C, Chavarri-Guerra Y, Sedrak M, Katheria V, Castillo D, et al.
J Geriatr Oncol . 2019 Oct; 11(2):316-319. PMID: 31575519
Objective: Our goal was to identify pathogenic variants (PV) associated with germline cancer predisposition in an unselected cohort of older breast cancer survivors. Older patients with cancer may also be...
8.
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
Palmero E, Carraro D, Alemar B, Moreira M, Ribeiro-Dos-Santos A, Abe-Sandes K, et al.
Sci Rep . 2018 Jun; 8(1):9188. PMID: 29907814
The detection of germline mutations in BRCA1 and BRCA2 is essential to the formulation of clinical management strategies, and in Brazil, there is limited access to these services, mainly due...
9.
Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
Alemar B, Gregorio C, Herzog J, Bittar C, Oliveira Netto C, Artigalas O, et al.
PLoS One . 2018 May; 13(5):e0197529. PMID: 29750819
[This corrects the article DOI: 10.1371/journal.pone.0187630.].
10.
Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry
Slavin T, Van Tongeren L, Behrendt C, Solomon I, Rybak C, Nehoray B, et al.
J Natl Cancer Inst . 2018 Apr; 110(10):1059-1066. PMID: 29618041
Background: In germline genetic testing, variants from understudied ancestries have been disproportionately classified as being of uncertain significance. We hypothesized that the rate of variant reclassification likewise differs by ancestry....